-+ 0.00%
-+ 0.00%
-+ 0.00%

HC Wainwright & Co. Initiates Coverage On Autolus Therapeutics with Buy Rating, Announces Price Target of $9

Benzinga·02/17/2026 11:37:29
Listen to the news
HC Wainwright & Co. analyst Emily Bodnar initiates coverage on Autolus Therapeutics (NASDAQ:AUTL) with a Buy rating and announces Price Target of $9.